戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 strates prior to large-scale production of a biological product.
2  quality and expected characteristics of the biological product.
3 trate for the development and manufacture of biological products.
4 ication or formulation and eight vaccines or biological products.
5 nly used cell substrate in the production of biological products.
6 ropriate in the preparation of some types of biological products.
7 e concepts have yet to be applied to complex biological products.
8 gned clinical studies of drugs, devices, and biological products.
9 accelerate the production and consumption of biological products.
10 photosynthesis, cilia, and the generation of biological products.
11 and licensing biosimilar and interchangeable biological products.
12 d structural differences between two or more biological products.
13 Bioassays play central role in evaluation of biological products and those derived from bacterial tox
14  frugiperda, is used as a cell substrate for biological products, and no viruses have been reported i
15 s to animal testing for purposes of drug and biological product applications." This provides an oppor
16 g on reducing to practice a stable, reliable biological product as an alternative to electronic pacem
17 or use in the LPS detection in foodstuff and biological products, as well as bacteria identification,
18                                      Defense Biological Product Assurance Office of the US Department
19                                      Defense Biological Product Assurance Office.
20  development of anti-drug Abs in response to biological products (BP) is a major drawback in the trea
21 boratory research animals and simian-derived biological products, could minimize human exposure to SF
22                       The growing demand for biological products drives many efforts to maximize expr
23 tbreak threats, screening vaccines and other biological products for microbial contamination, and dis
24  a large increase in the number and types of biological products--from therapeutic antibodies to vacc
25 ed formulations have been developed for many biological products including monoclonal antibodies (mAb
26 noclonal antibody development, as with other biological products, is understanding the properties of
27           Changes in production methods of a biological product may necessitate an assessment of comp
28 of an old debate on the safety assessment of biological products, namely whether the use of some type
29 l-carnitine, E. limosum excreted the unusual biological product norcarnitine as well as acetate, buty
30  process changes during the development of a biological product or post-approval.
31 annot be directly applied to the analysis of biological products or clinical samples without further
32 promised channels, easy-to-read barcoding of biological products, or provide a deterrent to counterfe
33 og (PTEN) is enhanced by the presence of its biological product, phosphatidylinositol 4,5-bisphosphat
34 s necessary to make a variety of competitive biological products regarding their equivalent products
35               Nuclear pharmacies that handle biological products should follow appropriate aseptic te
36  organic farming, has created a need for new biological products, such as thiocyclam, to control pest
37 products; one FDA-licensed rHuEPO originator biological product, three rHuEPO products that are appro
38 nt therapeutic proteins are a broad class of biological products used to replace dysfunctional human